CoChat

Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France

Vexiau, P., Mavros, P., Krishnarajah, G., Lyu, R., Yin, D. · 2008 · Diabetes, Obesity and Metabolism
Cited by 110

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Context: Hypoglycaemia from antihyperglycaemic drugs may have a significant impact on patients’ health‐related quality of life. Combination use of metformin and a sulphonylurea has become increasingly common; yet, the impact of hypoglycaemia on quality of life in these patients is not well documented. Objective: To examine patient‐reported experience of hypoglycaemia, worry about hypoglycaemic symptoms and the impact of hypoglycaemia on patients’ quality of life associated with use of sulphonylurea co‐administered with metformin. Design: This was an observational, cross‐sectional, multi‐centre study. Setting: A total of 98 primary care centres in France during October to December 2005. Patients: A total of 400 patients with type 2 diabetes, who were ≥35 years old and who had been treated with metformin and a sulphonylurea for at least 6 months, completed questionnaires during their usual primary care office visit. Main Outcome Measures: Frequency and severity of hypoglycaemic symptoms in the past 6 months, the Worry subscale of the Hypoglycaemic Fear Survey‐II (HFS‐II) and the EuroQol‐5 Dimensions (EQ‐5D) questionnaire. Results: A total of 136 (34%) patients reported experiencing hypoglycaemia, of whom 78 (58%) experienced mild, 40 (30%) experienced moderate and 16 (12%) experienced severe or very severe symptoms. Mean score on the HFS‐II Worry scale was higher for patients who reported having hypoglycaemia than for those who did not (19.0 vs. 10.2; p < 0.0001) and increased with severity of hypoglycaemic symptoms. In linear regression analyses, more severe symptoms of hypoglycaemia were significantly associated with higher scores on the HFS‐II Worry scale (p = 0.0162) among patients with hypoglycaemic symptoms. Summary scores on the EQ‐5D were lower for patients who reported hypoglycaemia than for those who did not (p = 0.0001) and, in multivariate analysis, the experience of hypoglycaemia was negatively associated with the EQ‐5D summary score (p < 0.0001). Conclusion: The occurrence and severity of hypoglycaemic symptoms were associated with increased patient worry about hypoglycaemia and lower health‐related quality of life among type 2 diabetic patients being treated with both metformin and a sulphonylurea.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2008.00883.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 110

Metadata

Authors
Vexiau, P., Mavros, P., Krishnarajah, G., Lyu, R., & Yin, D.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2008-04-23
Volume
10
Issue
s1
Pages
16-24
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2146286204
Cited by
110
References
6
FWCI
5.23
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. https://app.cochat.ai/papers/10.1111/j.1463-1326.2008.00883.x
The paper
Vexiau, P., Mavros, P., Krishnarajah, G., Lyu, R., & Yin, D. (2008). Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2008.00883.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.